Aug 3, 2021
August 03, 2021 07:00 AM Eastern Daylight Time WOBURN, Mass.–(BUSINESS WIRE)–ReForm Biologics, Inc., a company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced that John...
Jul 26, 2021
Absci IPO From a basement lab to Times Square! It was a thrill to ring the @Nasdaq closing bell today and light up NYC! #absci $ABSI...
Jul 23, 2021
Biotech CEOs tend to have advanced degrees and multiple academic credentials under their belt. But Sean McClain started Absci as a freshly minted grad from the University of Arizona at age 22, living with his parents and working out of a basement lab. Fast forward a...
Jul 2, 2021
Sean McClain started Absci as a 22-year-old college graduate in a small basement lab — or as he called it, a “dungeon lab” — in downtown Portland, OR. Ten years later, he’s taking the company public. Absci filed S-1 papers on Wednesday, penciling in a $100 million...
Jul 1, 2021
VANCOUVER, Wash., June 30, 2021 /PRNewswire/ — Absci Corporation (“Absci”), the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, announced today that it has filed a registration statement on Form S-1 with the U.S....
Jun 28, 2021
Green Theme Technologies (GTT), an American leader in creating sustainable solutions for the textile and fashion industries, has announced that it has raised $3.5 million at first close of series B financing. Funds raised will be used to grow GTT’s sustainable and...
